Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurie Spehner

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Bulletin Du Cancer|January 11, 2021
[Squamous cell anal carcinoma. What's next ?]Stefano Kim, Laurie Spehner, Luc Cabel, et al.
Cancers|August 7, 2021
Present and Future Research on Anal Squamous Cell CarcinomaLaurie Spehner, Jihane Boustani, Luc Cabel, et al.
Lab on a Chip|July 17, 2023
Microfluidic device combining hydrodynamic and dielectrophoretic trapping for the controlled contact between single micro-sized objects and application to adhesion assaysClémentine Lipp, Laure Koebel, Romain Loyon, et al.
International Journal of Molecular Sciences|September 22, 2020
Anti-Telomerase CD4<sup>+</sup> Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 TrialsLaurie Spehner, Stefano Kim, Angélique Vienot, et al.
Heliyon|September 27, 2024
Timing is essential: Humoral and cellular responses to SARS-CoV-2 vaccination in a cohort of patients with auto-immune diseases treated with rituximabIrène Gallais Sérézal, Laurie Spehner, Marie Kroemer, et al.
International Journal of Cancer|August 16, 2025
Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo-refractory gastrointestinal cancersLaurie Spehner, Adeline Bouard, Antoine El Kaddissi, et al.
Frontiers in Public Health|April 4, 2022
The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma DonorsMarie Kroemer, Laura Boullerot, Mélanie Ramseyer, et al.
Oncoimmunology|April 11, 2018
SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contextsMarie Kroemer, Laurie Spehner, Patricia Mercier-Letondal, et al.
Journal for Immunotherapy of Cancer|November 24, 2020
Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastasesMarie Kroemer, Celia Turco, Laurie Spehner, et al.
Cancer Research Communications|January 14, 2025
Stanniocalcin 1 in Patients with Refractory Colorectal Cancer Treated with Regorafenib: A Post Hoc Biomarker Analysis of the TEXCAN and CORRECT TrialsAngélique Vienot, Dewi Vernerey, Adeline Bouard, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer|January 11, 2021
[Squamous cell anal carcinoma. What's next ?]Stefano Kim, Laurie Spehner, Luc Cabel, et al.
Cancers|August 7, 2021
Present and Future Research on Anal Squamous Cell CarcinomaLaurie Spehner, Jihane Boustani, Luc Cabel, et al.
Lab on a Chip|July 17, 2023
Microfluidic device combining hydrodynamic and dielectrophoretic trapping for the controlled contact between single micro-sized objects and application to adhesion assaysClémentine Lipp, Laure Koebel, Romain Loyon, et al.
International Journal of Molecular Sciences|September 22, 2020
Anti-Telomerase CD4<sup>+</sup> Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 TrialsLaurie Spehner, Stefano Kim, Angélique Vienot, et al.
Heliyon|September 27, 2024
Timing is essential: Humoral and cellular responses to SARS-CoV-2 vaccination in a cohort of patients with auto-immune diseases treated with rituximabIrène Gallais Sérézal, Laurie Spehner, Marie Kroemer, et al.
International Journal of Cancer|August 16, 2025
Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo-refractory gastrointestinal cancersLaurie Spehner, Adeline Bouard, Antoine El Kaddissi, et al.
Frontiers in Public Health|April 4, 2022
The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma DonorsMarie Kroemer, Laura Boullerot, Mélanie Ramseyer, et al.
Oncoimmunology|April 11, 2018
SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contextsMarie Kroemer, Laurie Spehner, Patricia Mercier-Letondal, et al.
Journal for Immunotherapy of Cancer|November 24, 2020
Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastasesMarie Kroemer, Celia Turco, Laurie Spehner, et al.
Cancer Research Communications|January 14, 2025
Stanniocalcin 1 in Patients with Refractory Colorectal Cancer Treated with Regorafenib: A Post Hoc Biomarker Analysis of the TEXCAN and CORRECT TrialsAngélique Vienot, Dewi Vernerey, Adeline Bouard, et al.
Pageof 3